These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 8678620)

  • 21. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit.
    Moss A; Bourke MJ; Hourigan LF; Gupta S; Williams SJ; Tran K; Swan MP; Hopper AD; Kwan V; Bailey AA
    Am J Gastroenterol; 2010 Jun; 105(6):1276-83. PubMed ID: 20179694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical management of high-grade dysplasia in Barrett's esophagus.
    Rice TW; Falk GW; Achkar E; Petras RE
    Am J Gastroenterol; 1993 Nov; 88(11):1832-6. PubMed ID: 8237928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy.
    Ferguson MK; Naunheim KS
    J Thorac Cardiovasc Surg; 1997 Nov; 114(5):824-9. PubMed ID: 9375613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced esophageal cancer in patients who underwent radiofrequency ablation for barrett esophagus with high-grade dysplasia.
    Kim MP; Brown KN; Schwartz MR; Blackmon SH
    Innovations (Phila); 2013; 8(1):17-22. PubMed ID: 23571789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis.
    Lerut T; Coosemans W; Van Raemdonck D; Dillemans B; De Leyn P; Marnette JM; Geboes K
    J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1059-65; discussion 1065-6. PubMed ID: 8159027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
    Incarbone R; Bonavina L; Bassi F; Peracchia A
    Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience.
    Wang VS; Hornick JL; Sepulveda JA; Mauer R; Poneros JM
    Gastrointest Endosc; 2009 Apr; 69(4):777-83. PubMed ID: 19136106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controversies in Barrett's esophagus: management of high grade dysplasia.
    Sharma P
    Semin Gastrointest Dis; 2001 Jan; 12(1):26-32. PubMed ID: 11215852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance in Barrett's esophagus: an audit of practice.
    Ajumobi A; Bahjri K; Jackson C; Griffin R
    Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic follow-up of Barrett's esophagus: protocol and implications.
    De Looze D
    Acta Gastroenterol Belg; 2000; 63(1):29-35. PubMed ID: 10907316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions.
    Reid BJ; Weinstein WM; Lewin KJ; Haggitt RC; VanDeventer G; DenBesten L; Rubin CE
    Gastroenterology; 1988 Jan; 94(1):81-90. PubMed ID: 3335302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of dysplasia arising in Barrett's esophagus: a dynamic view.
    Romagnoli R; Collard JM; Gutschow C; Yamusah N; Salizzoni M
    J Am Coll Surg; 2003 Sep; 197(3):365-71. PubMed ID: 12946790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia.
    Falk GW; Rice TW; Goldblum JR; Richter JE
    Gastrointest Endosc; 1999 Feb; 49(2):170-6. PubMed ID: 9925694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia.
    Reid BJ; Blount PL; Feng Z; Levine DS
    Am J Gastroenterol; 2000 Nov; 95(11):3089-96. PubMed ID: 11095322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus.
    Hamilton SR; Smith RR
    Am J Clin Pathol; 1987 Mar; 87(3):301-12. PubMed ID: 3825997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma.
    Gilbert S; Jobe BA
    Surg Oncol Clin N Am; 2009 Jul; 18(3):523-31. PubMed ID: 19500741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
    Foroulis CN; Thorpe JA
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronology of the Barrett's metaplasia-dysplasia-carcinoma sequence.
    Theisen J; Nigro JJ; DeMeester TR; Peters JH; Gastal OL; Hagen JA; Hashemi M; Bremner CG
    Dis Esophagus; 2004; 17(1):67-70. PubMed ID: 15209744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.